Gene: BEND7
Official Full Name: BEN domain containing 7provided by HGNC
Gene Summary: Predicted to enable DNA binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27103 | BEND7 Knockout cell line (HCT 116) | Human | BEND7 | 1:2~1:4 | Negative | Online Inquiry |
KO27104 | BEND7 Knockout cell line (HEK293) | Human | BEND7 | 1:3~1:6 | Negative | Online Inquiry |
KO27105 | BEND7 Knockout cell line (A549) | Human | BEND7 | 1:3~1:4 | Negative | Online Inquiry |
BEND7 Gene Knockout Cell Lines are specialized cellular models that have been genetically modified to eliminate the expression of the BEND7 gene, an important factor implicated in various physiological processes and diseases. The knockout technique utilizes CRISPR-Cas9 gene-editing technology, which provides a highly precise and efficient method for disrupting gene function. By inhibiting the BEND7 gene, these cell lines allow researchers to study the consequences of its absence on cellular behavior, signaling pathways, and overall cellular physiology.
The primary function of BEND7 Gene Knockout Cell Lines is to serve as a versatile tool for investigating the gene's role in cellular activities, including differentiation, proliferation, and apoptosis. These models enable scientists to dissect the molecular mechanisms underlying various biological phenomena, as well as the pathogenesis of diseases in which BEND7 is implicated. In preclinical settings, these knockout lines can also facilitate drug testing, toxicity assessments, and biomarker discovery by providing a controlled environment that lacks specific gene expression.
The scientific importance of BEND7 Gene Knockout Cell Lines lies in their diverse applications across research and clinical laboratories. With the increasing relevance of personalized medicine and targeted therapies, these cellular models assist in understanding gene-function relationships and screening potential therapeutic compounds. In comparison to traditional cell lines, BEND7 knockout models offer unprecedented specificity by allowing investigators to accurately assess the phenotypic effects resulting from the absence of BEND7, thus overcoming several limitations of previous methodologies.
Researchers and clinicians will find tremendous value in employing BEND7 Gene Knockout Cell Lines due to their robustness and reliability in yielding reproducible results, which are pivotal for advancing scientific knowledge and therapeutic interventions. Additionally, our meticulously curated, user-friendly protocols ensure that even those new to gene editing can effectively implement these cell lines into their workflows.
At [Your Company Name], we pride ourselves on our state-of-the-art biotechnological expertise and commitment to providing high-quality biological products. Our BEND7 Gene Knockout Cell Lines exemplify our dedication to supporting the scientific community in their quest for innovative research that can lead to breakthroughs in health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.